NewsRoom Articles - Page 150 of 243

TuesdayMar 01, 2022 9:30 am

New Study Investigates Negative Effects of Being Obsessively Passionate About Your Job

New research has explained why being obsessively passionate about one’s job may have maladaptive and negative outcomes for a person. University of Manitoba professor Benjamin Schellenberg, the lead author of the study, stated that obsessively passionate individuals reported lower levels of psychological well-being and also experienced more stress, anxiety and negative emotions. The researchers’ objective was to find out why obsessive passion was common in the workplace, despite these negative consequences. For their study, the researchers carried out a series of studies that evaluated lay beliefs about passion from a number of perspectives. Every participant in each study was instructed…

MondayFeb 28, 2022 9:30 am

More Children Are Being Diagnosed with Diabetes after Pandemic

Type 1 diabetes is also referred to as insulin-dependent diabetes or juvenile diabetes. It’s a chronic condition in which the pancreas produces no insulin or little insulin. Insulin is a hormone required in the body that allows glucose (sugar) to enter cells in order to produce energy. Since the coronavirus pandemic began, doctors have observed a significant increase in diagnoses for type 1 diabetes, particularly in children. Various factors may contribute to the development of type 1 diabetes, the most common being genetics and exposure to some viruses, as well as other environmental factors. While this chronic condition usually appears…

MondayFeb 28, 2022 9:15 am

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Makes Exciting Drug Discovery for the Treatment of Mental health and Addiction Disorders – MYCO-005

Mydecine announced the inclusion of a patent-pending novel molecule in its family of psilocin analogs, MYCO-005 This molecule features potentially heart-safe microdose-enabling properties, addressing the delivery and stability concerns associated with the first-generation compounds Mydecine’s patent-pending dermal route to administration also offers more control over the drug while possibly eliminating undesirable properties such as nausea The company is excited about this finding, terming it one of the many exciting drug discoveries it looks to share in the near term Microdosing, the act of consuming a minimal dose of a psychedelic to benefit from what it offers without going through a…

FridayFeb 25, 2022 9:30 am

Experimental Herpes Virus May Help Fight Fatal Brain Cancer

A new study has found that an experimental herpes simplex virus may help fight glioblastoma brain tumors. Glioblastoma brain tumors have an average survival period of 12 to 15 months from when one individual receives a diagnosis and four to six months after they recur. Dr. James Markert, the study’s senior researcher, stated that despite almost six decades of research and advances in radiation, chemotherapy and surgery, not much has changed with regard to survival. Markert, who is chairman of neurosurgery at the Heersink School of Medicine, University of Alabama, added that only 5% to 10% of patients diagnosed with…

FridayFeb 25, 2022 9:15 am

Nemaura Medical Inc. (NASDAQ: NMRD) Publishes 3QFY2022 Results; Company Reports its Inaugural Quarterly Revenues

Nemaura Medical has recently reported its 3QFY2022 (4QCY2021) results, with the company recognizing its inaugural revenues of $183,628 over the quarter The company also announced that it held $23 million in cash reserves as of the end of the quarter, which should amply cover its cash requirements over the coming months Nemaura Medical seized upon the opportunity to update investors on their ongoing operational highlights, which include the appointment of Dr. Arash Ghadar as COO, the formal launch of their Miboko product line Finally, the company also announced a new investment received from Tiger Partners Trading LLC, an investment advisor…

ThursdayFeb 24, 2022 9:30 am

One’s View of the Future Could Facilitate Recovery from AUD

New research has found that altering the time perspective of individuals suffering from alcohol use disorder (“AUD”) can improve their recovery. The study, which was carried out by researchers at Virginia Tech, had its findings published in “Alcoholism: Clinical & Experimental Research.” Figures from the Substance Abuse and Mental Health Services Administration show that more than 15 million individuals in America suffer from alcohol use disorder, which creates an economic burden of almost $250 billion annually. Warren Bickel, the Carilion Behavioral Health Research Professor at Virginia Tech stated that the researchers had taken a new approach, which showed ways to…

WednesdayFeb 23, 2022 10:15 am

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) Communicating the Therapeutic Benefits of Psychedelics; Advocating for Accurate and Consistent Messaging to Promote The Acceptance of Psychedelics in Therapeutics

Studies suggest that psychedelics such as psilocybin and MDMA offer health benefits when used to treat patients with depression and PTSD These results have encouraged scientists, psychotherapists, and entrepreneurs, who say that FDA approvals may be on the horizon Mydecine is playing a vital role in pushing the knowledge of the benefits of psychedelic compounds by undertaking clinical research in partnership with academics In a recent interview, company CEO Josh Bartch emphasized the need for consistent messaging to push the adoption of psychedelics among the medical community, and help assuage concerns of patients who may be wary of psychedelic treatments…

WednesdayFeb 23, 2022 9:30 am

The Focus for Healthcare IT Professionals This Year

Most healthcare organizations have adapted to various changes since the coronavirus pandemic’s onset. In the last two years, these organizations have reduced a number of requirements and rules in an effort to speed up the changes required to address the pandemic, which is a big opportunity for innovation. Below are leadership strategies and technologies that CIOs can focus on this year to truly transform the IT and healthcare sectors. Develop accessible platforms Health systems currently have strong analytics tools that they use to extract data from health records. Finding ways to develop even better platforms that can access more comprehensive…

TuesdayFeb 22, 2022 9:30 am

Healthcare Providers Exhibiting PTSD Symptoms Similar to Veterans’

Recent studies have found that first responders and healthcare workers are displaying symptoms of PTSD that are similar to veterans who have served in combat. Researchers and healthcare providers believe that if administrators fail to find ways to offer relief to medical staff and hospitals that continue to be overwhelmed with COVID patients, many healthcare workers will leave areas where they care for coronavirus patients or leave the healthcare sector completely. This would further strain the capacity of hospitals to offer necessary care while staffing shortages increase. Dr. Rebecca Hendrickson, a VA Puget Health Care System clinical psychiatrist, stated that…

TuesdayFeb 22, 2022 9:30 am

AREV Life Sciences Global Corp. (CSE: AREV) (OTC: AREVF) Is ‘One to Watch’

In the first quarter of 2022, AREV acquired Wright & Well Essentials Inc., a firm with an extensive hemp and cannabis line of branded products currently sold in Oregon and expanding markets. The company’s online sales and marketing platform, Medicine Merchant™, is in the final stages of development; the platform has the potential to revolutionize consumer access to therapeutic interventions and personalized medicine via partnerships with telemedicine providers. A recent peer-reviewed study by a member of AREV’s scientific advisory board (“SAB”) has demonstrated the potential utility of specific cannabinoids against all variants of COVID-19. Further additions to AREV’s SAB in…